193 related articles for article (PubMed ID: 33100909)
1. High-throughput sequencing identification of differentially expressed microRNAs in metastatic ovarian cancer with experimental validations.
Gu Y; Zhang S
Cancer Cell Int; 2020; 20():517. PubMed ID: 33100909
[TBL] [Abstract][Full Text] [Related]
2. MiR-425-5p accelerated the proliferation, migration, and invasion of ovarian cancer cells via targeting AFF4.
Wu Z; Guo J; Zhang Y; Liu J; Ma H; Tang Y
J Ovarian Res; 2021 Oct; 14(1):138. PubMed ID: 34686190
[TBL] [Abstract][Full Text] [Related]
3. microRNA-1271-5p/TIAM1 suppresses the progression of ovarian cancer through inactivating Notch signaling pathway.
Han FJ; Li J; Shen Y; Guo Y; Liu YC; Yu Y; Xu JY; Liu SX; Wang YH
J Ovarian Res; 2020 Sep; 13(1):110. PubMed ID: 32948241
[TBL] [Abstract][Full Text] [Related]
4. Dual-strand tumor suppressor miR-193b-3p and -5p inhibit malignant phenotypes of lung cancer by suppressing their common targets.
Choi KH; Shin CH; Lee WJ; Ji H; Kim HH
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31262974
[TBL] [Abstract][Full Text] [Related]
5. F-Box and Leucine-Rich Repeat Protein 20 (FBXL20), Negatively Regulated by microRNA (miR)-195-5p, Accelerates the Malignant Progression of Ovarian Cancer.
Wu D; Liu C; Hong L
Mol Biotechnol; 2021 Dec; 63(12):1235-1243. PubMed ID: 34338995
[TBL] [Abstract][Full Text] [Related]
6. The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer.
Wang W; Yin Y; Shan X; Zhou X; Liu P; Cao Q; Zhu D; Zhang J; Zhu W
Am J Med Sci; 2019 Oct; 358(4):256-267. PubMed ID: 31353030
[TBL] [Abstract][Full Text] [Related]
7. Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker.
Vilming Elgaaen B; Olstad OK; Haug KB; Brusletto B; Sandvik L; Staff AC; Gautvik KM; Davidson B
BMC Cancer; 2014 Feb; 14():80. PubMed ID: 24512620
[TBL] [Abstract][Full Text] [Related]
8. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
Li Y; Li L
J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
[TBL] [Abstract][Full Text] [Related]
9. Exosome-transmitted miR-30a-5p enhances cell proliferation, migration, and invasion in ovarian cancer.
Cao J; Wang H; Yang J; Zhang J; Li D; Xu P
Cell Div; 2023 Nov; 18(1):20. PubMed ID: 37915096
[TBL] [Abstract][Full Text] [Related]
10. MiR-202-5p suppressed cell proliferation, migration and invasion in ovarian cancer via regulating HOXB2.
Yu HY; Pan SS
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2256-2263. PubMed ID: 32196576
[TBL] [Abstract][Full Text] [Related]
11. miRNA-199a-5p suppresses proliferation and invasion by directly targeting NF-κB1 in human ovarian cancer cells.
Liu X; Yao B; Wu Z
Oncol Lett; 2018 Oct; 16(4):4543-4550. PubMed ID: 30214589
[TBL] [Abstract][Full Text] [Related]
12. Circ_0078607 inhibits the progression of ovarian cancer via regulating the miR-32-5p/SIK1 network.
Jin Y; Wang H
J Ovarian Res; 2022 Jan; 15(1):3. PubMed ID: 34983607
[TBL] [Abstract][Full Text] [Related]
13. MIR100HG Regulates CALD1 Gene Expression by Targeting miR-142-5p to Affect the Progression of Bladder Cancer Cells
Zhang S; Wang Q; Li W; Chen J
Front Mol Biosci; 2021; 8():793493. PubMed ID: 35127818
[No Abstract] [Full Text] [Related]
14. MiRNA-mRNA integrative analysis reveals epigenetically regulated and prognostic miR-103a with a role in migration and invasion of carboplatin-resistant ovarian cancer cells that acquired mesenchymal-like phenotype.
Pernar Kovač M; Tadić V; Kralj J; Milković Periša M; Orešković S; Babić I; Banović V; Zhang W; Culig Z; Brozovic A
Biomed Pharmacother; 2023 Oct; 166():115349. PubMed ID: 37634476
[TBL] [Abstract][Full Text] [Related]
15. Identification and Functional Validation of Differentially Expressed microRNAs in Ascites-Derived Ovarian Cancer Cells Compared with Primary Tumour Tissue.
Jiang Y; Shi Y; Lyu T; Liu H; Shen L; Zhou T; Feng W
Cancer Manag Res; 2021; 13():6585-6597. PubMed ID: 34456588
[TBL] [Abstract][Full Text] [Related]
16. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
Hao T; Huang S; Han F
Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
[TBL] [Abstract][Full Text] [Related]
17. Five serum microRNAs for detection and predicting of ovarian cancer.
Wang W; Wu LR; Li C; Zhou X; Liu P; Jia X; Chen Y; Zhu W
Eur J Obstet Gynecol Reprod Biol X; 2019 Jul; 3():100017. PubMed ID: 31404211
[TBL] [Abstract][Full Text] [Related]
18. miR-96-5p promotes the proliferation and migration of ovarian cancer cells by suppressing Caveolae1.
Liu B; Zhang J; Yang D
J Ovarian Res; 2019 Jun; 12(1):57. PubMed ID: 31228941
[TBL] [Abstract][Full Text] [Related]
19. MiR-149-5p regulates cisplatin chemosensitivity, cell growth, and metastasis of oral squamous cell carcinoma cells by targeting TGFβ2.
Luo K; He J; Yu D; Açil Y
Int J Clin Exp Pathol; 2019; 12(10):3728-3739. PubMed ID: 31933761
[TBL] [Abstract][Full Text] [Related]
20. MiR-135b-5p affected malignant behaviors of ovarian cancer cells by targeting KDM5B.
Ren R; Wu J; Zhou MY
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3548-3554. PubMed ID: 32329828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
